1.
Human epidermal growth factor receptor 2 (HER-2) status evaluation in advanced gastric cancer using immunohistochemistry versus silver in situ hybridization. Biomol Biomed [Internet]. 2017 May 20 [cited 2024 Apr. 28];17(2):109-13. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/1497